Brief: Lavipharm 9-Month Adjusted EBITDA At EUR 9.1 Million, Up 21.2% YoY
14/11/2024 16:09
Nov 14 (Reuters) - Lavipharm SA LPHr.AT :
* 9-MONTH ADJUSTED EBITDA FROM CONTINUING OPERATIONS AT EUR
9.1
MILLION VERSUS EUR 7.6 MILLION YEAR AGO
* 9-MONTH NET PROFIT AT EUR 9.2 MILLION VERSUS EUR 2.1
MILLION
YEAR AGO
Further company coverage: LPHr.AT
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Lavipharm SA
See all newsBrief: Lavipharm Q1 Earnings Before Tax From Continuing Operations €1.41 Million, Up 28.6% YoY
Brief: Lavipharm To Acquire Durogesic Pain Patch Rights From Janssen For $12.0 Million
Brief: Lavipharm SA FY 2025 Earnings After Tax EUR 6.0 Million Versus EUR 9.0 Million Year Ago
Brief: Lavipharm 9-Month Net Profit Down To EUR 3.5 Million
Brief: Lavipharm H1 Adjusted EBITDA At EUR 7.7 Million, Up 29.4% YoY